Helen I. Torley Salary and Compensation - HALOZYME THERAPEUTICS, INC. CEO Salary 2025

In fiscal year 2025, Helen I. Torley, CEO of HALOZYME THERAPEUTICS, INC. (HALO), received total compensation of $23.2 million.

Helen I. Torley's compensation breakdown includes: base salary of $1 million, stock awards valued at $19.4 million, option awards of $1.7 million, non-equity incentive compensation of $1.1 million, and other compensation of $19K.

Compared to fiscal year 2024, Helen I. Torley's total compensation increased 449% from $4.2 million to $23.2 million.

HALOZYME THERAPEUTICS, INC. (HALO) Executive Pay 2025

HALOZYME THERAPEUTICS, INC.'s top 5 named executive officers received combined total compensation of $37.5 million in fiscal year 2025.

The named executive officers disclosed in HALOZYME THERAPEUTICS, INC.'s 2025 proxy statement are:Helen I. Torley with total compensation of $23.2 million, Nicole La Brosse with total compensation of $4.6 million, Mark Snyder with total compensation of $4.5 million, Cortney Caudill (Senior Vice President, Chief Operating Officer) with total compensation of $3.2 million, and Michael J. La Barre with total compensation of $2.1 million.